The association of urolithiasis and androgenetic alopecia

Basit Öğe Kaydı
dc.authoridgulpinar, murat tolga/0000-0001-9420-3009
dc.authoridArslan, Muhammet/0000-0001-5565-0770
dc.authoridAkbas, Alpaslan/0000-0003-1470-5952
dc.contributor.authorResorlu, Mustafa
dc.contributor.authorSancak, Eyup Burak
dc.contributor.authorUysal, Fatma
dc.contributor.authorArslan, Muhammet
dc.contributor.authorDiri, Akif
dc.contributor.authorAdam, Gurhan
dc.contributor.authorAkbas, Alpaslan
dc.date.accessioned2025-01-27T20:57:55Z
dc.date.available2025-01-27T20:57:55Z
dc.date.issued2016
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjectives: The objective of this study is to investigate whether patients with androgenetic alopecia were at risk in terms of urinary system stone disease. Patients and methods: Patients with no baldness (Hamilton-Norwood Scala [HNS] stage I) were categorized as Group I, those with hair loss in the frontal region (HNS stages II, III, IIIa, and IVa) as Group II, those with hair loss in the vertex region (HNS stage III-vertex, V) as Group III and those with hair loss in both vertex and frontal regions (HNS stages IV, Va, VI, and VII) as Group IV. Patients in all groups were compared in terms of presence of stone, and the presence of any association between alopecia and urolithiasis, with common etiological risk factors, was investigated. Results: Three hundred and two male patients were included in the study. The presence of urolithiasis was detected in 28.9% of patients in Group I; 26.5% of Group II; 36.9% of Group III; and 44.4% of Group IV (p= 0.085). Among patients aged under 60, urinary stone disease was detected in 30.8% of patients in Group I; 26.4% of Group II; 41.2% of Group III; and 53.8% of Group IV (p= 0.001). In patients aged over 60, urolithiasis was detected in 12.5% of patients in Group I; 26.9% of Group II; 32.2% of Group III; and 37.8% of Group IV (p= 0.371). Conclusions: We determined a significant correlation between vertex pattern and total alopecia with urolithiasis in patients younger than 60 years old.
dc.identifier.doi10.3109/0886022X.2015.1096729
dc.identifier.endpage88
dc.identifier.issn0886-022X
dc.identifier.issn1525-6049
dc.identifier.issue1
dc.identifier.pmid26460579
dc.identifier.scopus2-s2.0-84955745221
dc.identifier.scopusqualityQ2
dc.identifier.startpage84
dc.identifier.urihttps://doi.org/10.3109/0886022X.2015.1096729
dc.identifier.urihttps://hdl.handle.net/20.500.12428/26550
dc.identifier.volume38
dc.identifier.wosWOS:000368809300014
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofRenal Failure
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectAndrogenetic alopecia
dc.subjectultrasound
dc.subjecturolithiasis
dc.titleThe association of urolithiasis and androgenetic alopecia
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu